.Merck beats incomes requirements, increases sales overview on powerful demand for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Revenue Forecasts as Keytruda Purchases Growth BloombergMerck Supply: Pharma Giant Posts Tough End Results, However Outlook Drops Short Capitalist's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck trumps profit and also sales expectations surrounded by Keytruda strong point, yet gives combined full-year overview MarketWatch.